Cargando…
Development of a clinical diagnostic tool to differentiate multiple myeloma from bone metastasis in patients with destructive bone lesions (MM-BM DDx)
BACKGROUND: Most patients with destructive bone lesions undergo a comprehensive diagnostic procedure to ensure that proper treatment decisions are pursued. For patients with multiple myeloma, this can lead to delays in diagnosis and treatment initiation. This study was conducted to develop a diagnos...
Autores principales: | Phinyo, Phichayut, Maihom, Titinat, Phanphaisarn, Areerak, Kerdsinchai, Pakorn, Rattarittamrong, Ekarat, Patumanond, Jayanton, Pruksakorn, Dumnoensun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579980/ https://www.ncbi.nlm.nih.gov/pubmed/33087068 http://dx.doi.org/10.1186/s12875-020-01283-x |
Ejemplares similares
-
Correction: Development of a clinical diagnostic tool to differentiate multiple myeloma from bone metastasis in patients with destructive bone lesions (MM-BM DDx)
por: Phinyo, Phichayut, et al.
Publicado: (2022) -
Validation of a Diagnostic Model to Differentiate Multiple Myeloma from Bone Metastasis
por: Phinyo, Phichayut, et al.
Publicado: (2023) -
Clinical Implication of Circulating Tumor Cells Expressing Epithelial Mesenchymal Transition (EMT) and Cancer Stem Cell (CSC) Markers and Their Perspective in HCC: A Systematic Review
por: Orrapin, Santhasiri, et al.
Publicado: (2022) -
IMPDH2 and HPRT expression and a prognostic significance in preoperative and postoperative patients with osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2021) -
Natural disease progression and novel survival prediction model for hepatocellular carcinoma with spinal metastases: a 10-year single-center study
por: Phinyo, Phichayut, et al.
Publicado: (2020)